Gregory Oakes
Tracked across 1 events · 6 articles · First seen Aug 17, 2026 · Last active Aug 19, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Fulcrum Therapeutics and Slate Medicines have signed a definitive all-stock merger agreement to create a combined company focused on next-generation migraine treatments. The combined entity will operate as Slate Medicines and trade on Nasdaq under…
Impact: Gregory Oakes, CEO of Slate Medicines, will lead the combined company as CEO, playing a key role in its strategic direction.
Aug 17, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Gregory Oakes live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard